Glaucoma, Open-Angle: all 943 studies

Page 10 of 10. Open to participants first (118), then studies with results posted, then the rest; newest registration first within each.

• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293800Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293787Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293761Phase 3
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00288951Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00287521Phase 2
• Choroidal Blood Flow Response to Hand-grip Test in Progressive GlaucomaWithdrawnNCT00284440
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNCT00283764Phase 3
• Autoimmune Dysregulation in Pigmentary GlaucomaCompletedNCT00280345Not applicable
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
• Cosopt Versus XalacomCompletedNCT00273481Phase 4
• Lumigan Versus CosoptCompletedNCT00273455Phase 4
• Assessing Cosopt Switch PatientsCompletedNCT00273442Phase 4
• Cosopt Versus XalatanCompletedNCT00273429Phase 4
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureCompletedNCT00230763Phase 3
• African Descent and Glaucoma Evaluation StudyStatus unknownNCT00221923
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionCompletedNCT00219596Phase 3
• Memantine in Patients With Chronic GlaucomaCompletedNCT00168350Phase 3
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
• A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular HypertensionCompletedNCT00150267Phase 3
• SOLX Titanium Sapphire Laser for TrabeculoplastyCompletedNCT00145535Phase 3
• Corneal Versus Conjunctival Delivery Using a Delivery DeviceWithdrawnNCT00143429Phase 2
• Memantine in Patients With Chronic GlaucomaCompletedNCT00141882Phase 3
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.CompletedNCT00140062Phase 4
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedNCT00140049Phase 4
• Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanCompletedNCT00121147Not applicable
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069719Phase 2
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00069706Phase 2
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00061529Phase 3
• A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT00051194Phase 2
• A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)CompletedNCT00051155Phase 3
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT00051142Phase 3
• Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32TerminatedNCT00047606Phase 4
• Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98CompletedNCT00047593Phase 3
• Study of TRAVATAN in Subjects With Iris Pigmentation ChangesTerminatedNCT00047554
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70CompletedNCT00047541Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41CompletedNCT00047528Phase 3
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69CompletedNCT00047515Phase 3
• Cause of Pigment Dispersion SyndromeCompletedNCT00005919
• Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and LensCompletedNCT00001161
• Pigment Dispersion Syndrome With and Without GlaucomaCompletedNCT00001152
• Collaborative Initial Glaucoma Treatment Study (CIGTS)Status unknownNCT00000149Phase 3
• Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)CompletedNCT00000144Phase 3
• Early Manifest Glaucoma Trial (EMGT)Status unknownNCT00000132Phase 3

← Glaucoma, Open-Angle overview